BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1355596)

  • 1. Supraspinal administration of [D-Met2]FMRFamide produces a naloxone-sensitive increase in heart rate in unrestrained spontaneously hypertensive rats.
    Raffa RB; Addo MF; Gill A
    Neuropeptides; 1992 Apr; 21(4):201-5. PubMed ID: 1355596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activity.
    Raffa RB
    Peptides; 1989; 10(2):403-6. PubMed ID: 2755878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
    Raffa RB; Connelly CD
    Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D-Met2]-FMRFamide (DMFa): production of naloxone-sensitive antinociception in mouse tail-flick test.
    Raffa RB; Connelly CD
    NIDA Res Monogr; 1990; 105():391-2. PubMed ID: 1876049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Phe-D-Met-Arg-Phe-NH2 and other Phe-Met-Arg-Phe-NH2-related peptides on mouse colonic propulsive motility: a structure-activity relationship study.
    Raffa RB; Jacoby HI
    J Pharmacol Exp Ther; 1990 Sep; 254(3):809-14. PubMed ID: 1975622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice.
    Raffa RB; Jacoby HI
    Peptides; 1989; 10(4):873-5. PubMed ID: 2587427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat.
    Gouardères C; Sutak M; Zajac JM; Jhamandas K
    Eur J Pharmacol; 1993 Jun; 237(1):73-81. PubMed ID: 8102975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu receptor and Gi2alpha antisense attenuate [D-Met2]-FMRFamide antinociception in mice.
    Raffa RB; Stone DJ
    Peptides; 1998; 19(7):1171-5. PubMed ID: 9786166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Phe-Met-Arg-Phe-NH2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice.
    Jacoby MB; Jacoby HI; Mathiasen JR; Raffa RB
    Neurosci Lett; 1987 Dec; 83(1-2):128-32. PubMed ID: 3441291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system.
    Thiemermann C; al-Damluji S; Hecker M; Vane JR
    Biochem Biophys Res Commun; 1991 Feb; 175(1):318-24. PubMed ID: 1998514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMRFamide suppresses kappa opiate induced feeding in the mouse.
    Kavaliers M; Hirst M
    Peptides; 1985; 6(5):847-9. PubMed ID: 3001666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal FMRFamide (Phe-Met-Arg-Phe-NH2) induces excessive grooming behavior in mice.
    Raffa RB; Heyman J; Porreca F
    Neurosci Lett; 1986 Mar; 65(1):94-8. PubMed ID: 2422608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions of FMRF-NH2 and FMRF-NH2 related peptides on mammals.
    Raffa RB
    NIDA Res Monogr; 1990; 105():243-9. PubMed ID: 1678861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of intraventricular injection of FMRFamide, Met-enkephalin and their common analogues in the rat.
    Wong TM; Greenberg MJ; Tse SY
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):175-9. PubMed ID: 2861046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could dual G-protein coupling explain [D-Met2]FMRFamide's mixed action in vivo?
    Raffa RB; Stone DJ
    Peptides; 1996; 17(8):1261-5. PubMed ID: 8971917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phe-Met-Arg-Phe-amide (FMRFamide) stimulated growth hormone secretion in conscious OVX rats.
    Ottlecz A; Telegdy G
    Neuropeptides; 1987; 9(2):161-7. PubMed ID: 3574609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropeptide Phe-Met-Arg-Phe-NH2 (FMRFamide) can activate a ligand-gated ion channel in Helix neurones.
    Cottrell GA; Green KA; Davies NW
    Pflugers Arch; 1990 Jul; 416(5):612-4. PubMed ID: 1700364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice.
    Kavaliers M
    Neurosci Lett; 1990 Jul; 115(2-3):307-12. PubMed ID: 2234508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FMRFamide, a putative endogenous opiate antagonist: evidence from suppression of defeat-induced analgesia and feeding in mice.
    Kavaliers M; Hirst M
    Neuropeptides; 1985 Dec; 6(6):485-94. PubMed ID: 4080110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat.
    Holland LN; Shuster LC; Buccafusco JJ
    Neuropharmacology; 1993 Dec; 32(12):1387-95. PubMed ID: 8152529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.